The FreeMind Group 8th Annual Non-Dilutive Funding Day

Join us on January 9th, 2013 in San Francisco for the FreeMind Group Non-dilutive Funding Day!

FreeMind is proud to host Dr Gary Disbrow, the Deputy Director of the Biomedical Advanced Research and Development Authority (BARDA) who will share his insight into BARDA's specific needs, interests, and available funding for the Life Science indsutry, with an emphasis on CBRN threats.

FreeMind will kickoff the event with a "2013 Non-dilutive funding forecast" provided by FreeMind's Managing Partner, Ram May-Ron. Followed, will take place a panel discussion on industry success stories in turning non-dilutive funding into a strategic source of funding. In aggregate, our panelists have secured over $200M from government sources!

Agenda:

8:30 - 9:00 AM

Breakfast and Networking

9:00 - 10:00 AM

Presentation - Non-dilutive Funding Forecast 2013

Ram May-Ron, Managing Partner - FreeMind Group

10:15 - 11:30 AM

Panel discussion - Industry success stories - Turing non-dilutive funding into a strategic source of funding for the life science industry

Russell Skibsted, CFO - Aeolus Pharmaceuticals Inc.

Hugh A. Haydon, Chairman - Kentucky Bioprocessing, LLC

Cynthia Collins, President and CEO - Genvec Inc.

Stephen Hoffman, CEO and CSO - Sanaria Inc.

Will Joseph, Director of Government Affairs - Novadigm Therapeutics Inc.

12:00 - 1:00 PM

Break

2:30 - 4:00 PM

Key Note address - BARDA CBRN Funding opporutnities for Life Science organizations with an emphasis on CBRN threats

Dr Gary Disbrow

Deputy Director, Division of Chemical, Biological, Radiological, and Nuclear Countermeasures
Biomedical Advanced Research and Development Authority (BARDA)

11:30 AM- 12:00 PM; 1:00 - 2:30 PM; 4:00 - 4:30 PM

Meet the expert - Round table discussions

Guy Harchen, Chief Analyst, FreeMind Group

[Take the survey to request a field of study to be discussed]